High-dose-rate intraoperative radiotherapy for close or positive margins in patients with locally advanced or recurrent rectal cancer
Joost J. Nuyttens(Erasmus MC Cancer Institute), Peter C. Levendag(Erasmus MC Cancer Institute), Floris Ferenschild(Erasmus MC Cancer Institute), Wilfried J. Graveland(Erasmus MC Cancer Institute), Johannes H.W. de Wilt(Radboud University Nijmegen), Maarten Vermaas(Association of British Orchestras), Inger‐Karine K. Kolkman‐Deurloo(Erasmus University Rotterdam), Patrick E. J. Hanssens(Erasmus University Rotterdam)
International Journal of Radiation Oncology*Biology*Physics
December 19, 2003
Cited by 97
Related Papers
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
|The Lancet. Gastroenterology & hepatology|2019|326
Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study)
|British journal of surgery|2015|195
Total Pelvic Exenteration for Primary and Recurrent Malignancies
|World Journal of Surgery|2009|193